Portal vein thrombosis: A concise review

American Journal of Gastroenterology

Volumn 97, Issue 3, 2002, Pages 535-541

  Sobhonslidsuk, Abhasnee ^a   Reddy, K Rajender ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; ASPARAGINASE; FIBRINOLYTIC AGENT; HEMOPOIETIC GROWTH FACTOR; HEPARIN; HORMONE; PROPRANOLOL; TAMOXIFEN;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; DOPPLER ECHOGRAPHY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIVER TRANSPLANTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE;

HUMANS; PORTAL VEIN; VENOUS THROMBOSIS;

EID: 0036126279     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)04089-8     Document Type: Review

References (79)

1. Portal hypertension
2. The portal venous system and portal hypertension
3. Case of enlarged spleen complicated with ascites, both depending upon varicose dilatation and thrombosis of the portal vein
4. Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients
5. Hemodynamic during liver transplant: The interaction between cardiac output and portal venous and hepatic arterial flow
6. Portal vein thrombosis in adults: Pathophysiology, pathogenesis and management. A review
7. Portal vein thrombosis: A review
8. Hemodynamic changes in patients with portal venous obstruction
9. The aetiology, presentation and natural history of extrahepatic portal venous obstruction
10. Extrahepatic portal hypertension. A retrospective analysis of 127 cases and associated clinical implications
11. Extrahepatic portal vein thrombosis: Frequent recognition of associated diseases
12. Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders
13. Hypercoagulable state: Molecular genetics to clinical practice
14. Venous thrombosis: A multicausal disease
15. Familial thrombophilia: Genetic risk and management
16. Factor V Leiden and other coagulation factor mutation affecting thrombotic risk
17. Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3 untranslated region of the prothrombin gene
18. Increased risk for venous thrombosis in carriers of the prothrombin G→A20210 gene variant
19. Activated protein C resistance and thrombosis: Molecular mechanisms of hypercoagulable state due to FVR506Q mutation
20. The role of natural anticoagulant deficiencies and factor V Leiden in the development of idiopathic portal vein thrombosis
21. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis
22. Cause of portal and hepatic venous thrombosis in adults: The role of multiple concurrent factors
23. The incidence of protein C deficiency in thrombosis-related portal hypertension
24. A case of portal thrombosis associated with protein S deficiency
25. Postoperative portal vein obstruction in patients with idiopathic portal hypertension
26. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation
27. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
28. Current outcome of portal vein thrombosis in adults: Risk and benefit of anticoagulant therapy
29. Portal thrombosis: High incidence following splenectomy for portal hypertension
30. Portal vein thrombosis and fatal pulmonary thromboembolism associated with oral contraceptive treatment
31. Thrombophilia in pregnancy
32. Thrombophillas: Diagnosis and treatment of thrombophilia relating to contraception and pregnancy
33. Protean manifestations of the pylethrombosis. A review of thirty-four patients
34. High rate of portal thrombosis after splenectomy in patients with esophageal varices and idiopathic portal hypertension
35. Portal hypertension due to extrahepatic portal venous obstruction. A review of 40 cases
36. Coagulation abnormalities in malignancy
37. Thrombosis and cancer
38. Pathophysiology of the thrombophilic state in the cancer patient
39. The thrombophilic state induced by therapeutic agents in the cancer patient
40. Portal obstruction in children. I. Clinical investigation and hemorrhage risk
41. Spontaneous (natural) splenoadrenal shunts in extrahepatic portal venous obstruction: A series of 20 cases
42. Septic thrombophlebitis of the portal vein (pylephlebittis): Diagnosis and management in the modern era
43. Pylephlebitis. A case report and review of outcome in the antibiotic era
44. The role of anticoagulant in pylephlebitis
45. Extrahepatic portal obstruction - Clinical experience and surgical treatment in 105 patients
46. The liver
47. Color doppler ultrasonography in the diagnosis of cavernous transformation of the portal vein
48. Portal vein thrombosis: Image findings
49. MR, CT, and ultrasonography of splanchnic venous thrombosis
50. Portal vein thrombosis in adults undergoing liver transplantation. Risk factors, screening, management and outcome
51. MR imaging of the complications after liver transplantation
52. Contrast-enhanced three-dimensional MR portography
53. Three-dimensional gadolinium-enhanced MR angiography of vascular complications after liver transplantation
54. Clinical features, diagnosis and outcome of acute portal vein thrombosis
55. Recent portal or mesenteric venous thrombosis: Increased recognition and frequent recanalization on anticogulant therapy
56. Mesenteric and portal venous thrombosis treated by transjugular mechanical thrombolysis
57. Limitation of percutaneous techniques in the treatment of portal vein thrombosis
58. Hyperkinetic circulatory syndrome in patients with presinusoidal portal hypertension. Effect of propanolol
59. A 15-year experience of injection sclerotherapy in adult patients with extrahepatic portal venous obstruction
60. Portal venous thrombosis: Percutaneous therapy and outcome
61. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion
62. Implication of surgical treatment for advance hepatocellular carcinoma with tumor thrombi in the portal vein
63. An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation
64. Liver transplantation in adults
65. Portal vein grafts in hepatic transplantation
66. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation
67. Adult liver transplantation and abnormalities of splanchnic veins: Experience in 53 patients
68. Liver transplantation in patients with portal vein thrombosis
69. Liver transplantation in patients with thrombosis of the portal, splenic or superior mesenteric vein
70. Extra-anatomic venous graft for portal vein thrombosis in liver transplantation
71. Improved results of liver transplantation in patients with portal vein thrombosis
72. The spectrum of portal vein thrombosis
73. Liver transplantation with cavoportal hemitransposition in the presence of diffused portal vein thrombosis
74. Changing perspective in portal vein thrombosis and liver transplantation
75. Vascular complications after orthotopic liver transplantation
76. Complications of orthotopic liver transplantation
77. Vascular complication of liver transplantation: Evaluation with gadolinium-enhanced MR angiography
78. Percutaneous portal vein thrombosis and endovascular stent for management of posttransplant portal venous conduit thrombosis
79. Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation